Colorectal Cancer Diagnostics Market
Colorectal Cancer Diagnostics Market Scope: Industry Analysis, Market Size, Growth, Trends Till
Request Sample Report
2031
Colorectal Cancer Diagnostics Market Size and Growth
The global Colorectal Cancer Diagnostics market is expected to grow significantly due to increasing prevalence of colorectal cancer. Technological advancements in diagnostic tools and rising awareness about early detection are driving market growth. The market size is estimated to reach USD 2.5 billion by 2025, with North America dominating the market share. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Biocept
◍ Cancer Genetics
◍ Foundation Medicine
◍ Sysmex Corporation
◍ Danaher Corporation
◍ Epigenomics
◍ Illumina
◍ Rosetta Genomics
◍ Exact Science Corporation
◍ Pathway Genomics Corporation
The Competitive Landscape of Colorectal Cancer Diagnostics Market includes companies like Biocept, Cancer Genetics, Foundation Medicine, Sysmex Corporation, Danaher Corporation, Epigenomics, Illumina, Rosetta Genomics, Exact Science Corporation, and Pathway Genomics Corporation. These companies offer a range of diagnostic tools and services for colorectal cancer detection, prognosis, and treatment monitoring. They drive market growth by developing innovative technologies, collaborating with healthcare providers, and expanding their reach globally.
- Biocept: $16.5 million in sales revenue
- Foundation Medicine: $154 million in sales revenue
- Illumina: $3.3 billion in sales revenue
Request Sample Report
Market Segmentation
By Application
Hospitals
Specialty Clinics
Others
Request Sample Report
By Product
FOB Tests
CTC Tests
CEA Tests
Others
◍
◍
◍
◍
◍
◍
◍
Market Growth
Request Sample Report
$ 25.20 Billion
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients